NeurAxis (NRXS) Competitors $3.15 -0.12 (-3.67%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends NRXS vs. ECOR, LNSR, VANI, TELA, MGRM, MODD, HYPR, NSPR, APT, and LUCDShould you be buying NeurAxis stock or one of its competitors? The main competitors of NeurAxis include electroCore (ECOR), LENSAR (LNSR), Vivani Medical (VANI), TELA Bio (TELA), Monogram Orthopaedics (MGRM), Modular Medical (MODD), Hyperfine (HYPR), InspireMD (NSPR), Alpha Pro Tech (APT), and Lucid Diagnostics (LUCD). These companies are all part of the "medical equipment" industry. NeurAxis vs. electroCore LENSAR Vivani Medical TELA Bio Monogram Orthopaedics Modular Medical Hyperfine InspireMD Alpha Pro Tech Lucid Diagnostics electroCore (NASDAQ:ECOR) and NeurAxis (NASDAQ:NRXS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, community ranking, risk, profitability, valuation and earnings. Do insiders and institutionals hold more shares of ECOR or NRXS? 26.7% of electroCore shares are held by institutional investors. Comparatively, 11.8% of NeurAxis shares are held by institutional investors. 19.7% of electroCore shares are held by insiders. Comparatively, 15.2% of NeurAxis shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has more risk & volatility, ECOR or NRXS? electroCore has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500. Comparatively, NeurAxis has a beta of 4.27, indicating that its stock price is 327% more volatile than the S&P 500. Does the media refer more to ECOR or NRXS? In the previous week, electroCore had 8 more articles in the media than NeurAxis. MarketBeat recorded 15 mentions for electroCore and 7 mentions for NeurAxis. NeurAxis' average media sentiment score of 0.85 beat electroCore's score of 0.60 indicating that NeurAxis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment electroCore 6 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NeurAxis 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor ECOR or NRXS? electroCore received 163 more outperform votes than NeurAxis when rated by MarketBeat users. However, 100.00% of users gave NeurAxis an outperform vote while only 62.12% of users gave electroCore an outperform vote. CompanyUnderperformOutperformelectroCoreOutperform Votes16462.12% Underperform Votes10037.88% NeurAxisOutperform Votes1100.00% Underperform VotesNo Votes Do analysts rate ECOR or NRXS? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score electroCore 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00NeurAxis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is ECOR or NRXS more profitable? electroCore has a net margin of -54.40% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat electroCore's return on equity.Company Net Margins Return on Equity Return on Assets electroCore-54.40% -154.45% -69.16% NeurAxis -492.76%N/A -641.25% Which has higher earnings and valuation, ECOR or NRXS? NeurAxis has lower revenue, but higher earnings than electroCore. electroCore is trading at a lower price-to-earnings ratio than NeurAxis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioelectroCore$16.03M4.47-$18.83M-$1.83-5.98NeurAxis$2.46M8.94-$14.63M-$1.84-1.71 SummaryelectroCore beats NeurAxis on 10 of the 17 factors compared between the two stocks. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Get NeurAxis News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRXS vs. The Competition Export to ExcelMetricNeurAxisElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.99M$3.61B$5.17B$8.74BDividend YieldN/A1.65%5.18%4.08%P/E Ratio-1.7113.3764.9214.18Price / Sales8.9496.981,273.3887.02Price / CashN/A46.1739.7935.24Price / Book-12.123.806.485.93Net Income-$14.63M$92.21M$120.04M$225.73M7 Day Performance31.25%-2.39%-5.13%-1.34%1 Month Performance6.78%13.84%-2.72%1.15%1 Year Performance32.91%26.34%31.17%24.02% NeurAxis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRXSNeurAxisN/A$3.15-3.7%N/A+23.0%$21.99M$2.46M-1.7119News CoverageGap UpECORelectroCore0.8768 of 5 stars$13.60+1.5%N/A+80.2%$87.68M$21.28M-6.1850Short Interest ↑Analyst RevisionNews CoverageHigh Trading VolumeLNSRLENSAR3.1184 of 5 stars$7.20-2.6%N/A+237.1%$83.59M$42.16M-4.93110Short Interest ↓VANIVivani Medical3.1662 of 5 stars$1.44+3.6%N/A+37.9%$79.57MN/A-3.0620Insider BuyingNews CoveragePositive NewsGap UpTELATELA Bio4.0286 of 5 stars$3.04-0.7%N/A-38.5%$75.12M$58.45M-1.80120Short Interest ↓MGRMMonogram Orthopaedics0.9658 of 5 stars$2.01-5.2%N/A-26.0%$69.73M$370,000.00-5.9128Upcoming EarningsNews CoverageMODDModular Medical3.454 of 5 stars$2.14-4.0%N/A+97.1%$69.68MN/A-3.1539News CoverageHYPRHyperfine2.208 of 5 stars$0.89+2.3%N/A-31.9%$64.56M$11.03M-1.56190Earnings ReportNews CoverageNSPRInspireMD2.5246 of 5 stars$2.55+1.6%N/A-12.8%$63.57M$6.20M-3.4050Earnings ReportGap DownAPTAlpha Pro TechN/A$5.25-0.2%N/A+15.2%$57.70M$61.23M14.18120News CoverageLUCDLucid Diagnostics3.2939 of 5 stars$1.01-3.8%N/A-25.2%$54.53M$2.43M-0.8270Analyst ForecastShort Interest ↓News CoverageHigh Trading Volume Related Companies and Tools Related Companies electroCore Alternatives LENSAR Alternatives Vivani Medical Alternatives TELA Bio Alternatives Monogram Orthopaedics Alternatives Modular Medical Alternatives Hyperfine Alternatives InspireMD Alternatives Alpha Pro Tech Alternatives Lucid Diagnostics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NRXS) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeurAxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeurAxis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
